With the stock's price at Rs 3222.50, Torrent Pharmaceuticals' performance reflects its position in the pharmaceutical sector.

Mumbai: Torrent Pharmaceuticals on Wednesday reported a 0.99 per cent quarter-on-quarter (QoQ) decline in its net profit for the fourth quarter (Q4) of FY25, with earnings dropping to Rs 498 crore ...

Q4 Results May 20, 2025 updates: Find all the latest Q4 results 2025 updates for Hindalco Industries, Torrent Pharmaceuticals, Gland Pharma, Solar Industries India, Dixon Technologies, Whirlpool of ...

Benchmark NSE Nifty50 index ended down 203.75 points at 24609.7, while the BSE Sensex stood down 644.64 points at 80951.99.

The drug regulators in the country have reported a significant jump in the number of Not of Standard Quality (NSQ) drug samples in the routine regulatory surveillance activity during the month of ...

The rally is being fuelled by solid quarterly results and a string of optimistic fiscal 2026 outlooks from leading drugmakers.

India’s branded pharma market is under pressure as Jan Aushadhi and other generic channels gain momentum, impacting volume ...

An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K.

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make the body's ...

Visit a quote page and your recently viewed tickers will be displayed here.

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...